Tonix Pharmaceuticals Holding Corp (TNXP) stock is lower by -73.74% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives TNXP stock a score of 5 out of a possible 100. That rank is mainly influenced by a fundamental score of 0. TNXP stock has a mean target price of $2.13. This means analysts expect the stock to rise 717.31% over the next 12 months. TNXP's rank also includes a long-term technical score of 2. The short-term technical score for TNXP is 14.
Is Tonix Pharmaceuticals Holding Corp (TNXP) Stock a Attractive Value?
TNXP has an Overall Score of 5. Find out what this means to you and get the rest of the rankings on TNXP!